Ipilimumab/pembrolizumabInflammatory polyarthritis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1735卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56779-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：163 / 163

相关论文

共 50 条

[41] Ipilimumab/NivolumabMyocarditis: case report
Reactions Weekly, 2025, 2050 (1) : 284 - 284
[42] Ipilimumab/nivolumabVitiligo: case report
Reactions Weekly, 2019, 1769 (1) : 262 - 262
[43] Ipilimumab/nivolumabColitis: case report
Reactions Weekly, 2020, 1826 (1) : 185 - 185
[44] Ipilimumab/nivolumabHypopituitarism : case report
Reactions Weekly, 2022, 1907 (1) : 267 - 267
[45] Ipilimumab/nivolumabTransaminitis: case report
Reactions Weekly, 2018, 1729 (1) : 152 - 152
[46] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2019, 1747 (1) : 159 - 159
[47] Ipilimumab/nivolumabColitis: case report
Reactions Weekly, 2023, 1942 (1) : 157 - 157
[48] Ipilimumab/nivolumabNeurosarcoidosis: case report
Reactions Weekly, 2018, 1716 (1) : 170 - 170
[49] Ipilimumab/nivolumabPancreatitis: case report
Reactions Weekly, 2022, 1924 (1) : 259 - 259
[50] Ipilimumab/pembrolizumabHypophysitis: case report
Reactions Weekly, 2022, 1909 (1) : 306 - 306

← 1 2 3 4 5 →